XML 22 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION (Details) (USD $)
0 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2013
May 13, 2010
2010 Omnibus Incentive Plan
Dec. 31, 2013
2010 Omnibus Incentive Plan
May 13, 2010
2002 Stock Incentive and Bonus Plan and 2003 Non-Employee Directors' Stock Incentive Plan
Dec. 31, 2013
Incentive stock options
Dec. 31, 2012
Incentive stock options
Dec. 31, 2011
Incentive stock options
Dec. 31, 2013
Incentive stock options
Employee Awards
Dec. 31, 2012
Incentive stock options
Employee Awards
Dec. 31, 2010
Incentive stock options
Employee Awards
Dec. 31, 2013
Incentive stock options
Director Awards
Dec. 31, 2012
Incentive stock options
Director Awards
Dec. 31, 2011
Incentive stock options
Director Awards
Dec. 31, 2011
Incentive stock options
Non-Qualified Awards
May 13, 2010
Incentive stock options
2010 Omnibus Incentive Plan
Dec. 31, 2013
Restricted stock units
Dec. 31, 2012
Restricted stock units
Dec. 31, 2011
Restricted stock units
Dec. 31, 2013
Restricted stock units
Employee Awards
Dec. 31, 2012
Restricted stock units
Employee Awards
Dec. 31, 2011
Restricted stock units
Employee Awards
Dec. 31, 2013
Restricted stock units
Director Awards
Dec. 31, 2012
Restricted stock units
Director Awards
Dec. 31, 2011
Restricted stock units
Director Awards
Dec. 31, 2013
Restricted stock units
2010 Omnibus Incentive Plan
Stock Based Compensation                                                  
Shares of common stock reserved for issuance   2,500,000                                              
Shares of common stock authorized for issuance under the share-based compensation plan   2,000,000                         1,500,000                    
Number of shares of available for future issuance 1,100,000   1,100,000 500,000                                          
Plan expiration unless earlier terminated by the Board of Directors   10 years                                              
Shares of common stock issued under the Plan     1,600,000                                            
Number of authorized shares canceled     200,000                                            
Unrecognized stock-based compensation expense related to non-vested stock         $ 0 $ 0 $ 0                 $ 14,300,000                 $ 14,300,000
Period over which unrecognized stock-based compensation cost will be expensed                                                 4 years
The weighted average period over which unrecognized share-based compensation cost will be expensed                               2 years                  
Stock-based compensation expense                               9,000,000 8,100,000 8,100,000              
Shares                                                  
Nonvested at the beginning of the period (in shares)                                     811,559 893,523 808,071 121,356 115,918 133,754  
Granted (in shares)                                     371,111 468,500 487,620 71,651 63,497 59,698  
Vested (in shares)                               (370,006) (376,986) (436,600) (262,860) (318,927) (374,067) (107,146) (58,059) (62,533)  
Forfeited (in shares)                                     (53,174) (231,537) (28,101) (997)   (15,001)  
Nonvested at the end of the period (in shares)                                     866,636 811,559 893,523 84,864 121,356 115,918  
Weighted Average Grant Date Fair Value                                                  
Nonvested at the beginning of the period (in dollars per share)                                     $ 21.76 $ 21.84 $ 16.33 $ 22.62 $ 21.12 $ 16.38  
Granted (in dollars per share)                                     $ 29.35 $ 20.47 $ 25.25 $ 26.05 $ 22.35 $ 25.72  
Vested (in dollars per share)                                     $ 21.58 $ 20.17 $ 14.61 $ 20.69 $ 19.34 $ 15.46  
Forfeited (in dollars per share)                                     $ 22.81 $ 21.26 $ 19.17 $ 25.72   $ 20.80  
Nonvested at the end of the period (in dollars per share)                                     $ 25.00 $ 21.76 $ 21.84 $ 27.92 $ 22.62 $ 21.12  
Intrinsic value of shares fully vested during the period                               7,900,000 7,600,000 6,400,000              
Value of grants during the period                               12,800,000 11,000,000 13,300,000              
Shares                                                  
Outstanding at the beginning of the period (in shares)               203,000 434,500 434,500 18,855 28,259 80,091 376,000                      
Terminated (in shares)               (3,000) (1,500)       (10,373)                        
Exercised (in shares)               (200,000) (230,000)   (5,535) (9,404) (41,459) (376,000)                      
Outstanding at the end of the period (in shares)                 203,000 434,500 13,320 18,855 28,259                        
Weighted Average Exercise Price                                                  
Outstanding at the beginning of the period (in dollars per share)               $ 11.88 $ 13.45 $ 13.45 $ 10.02 $ 11.99 $ 11.08 $ 5.95                      
Terminated (in dollars per share)               $ 12.10 $ 15.60       $ 10.79                        
Exercised (in dollars per share)               $ 11.88 $ 14.82   $ 11.21 $ 16.04 $ 10.38 $ 5.98                      
Outstanding at the end of the period (in dollars per share)                 $ 11.88 $ 13.45 $ 9.53 $ 10.02 $ 11.99                        
Aggregate intrinsic value                     126,956                            
Weighted average remaining contractual term                     1 year                            
Intrinsic value of options exercised         2,400,000 3,600,000 2,700,000                                    
Options exercisable (in shares)         13,320 221,855 462,759                                    
Weighted average exercise price of options exercisable (in dollars per share)         $ 9.53 $ 11.72 $ 13.36                                    
Average remaining contractual term of options exercisable         1 year 1 year 1 year 8 months 12 days                                    
Aggregate intrinsic value of exercisable options         100,000 2,600,000 6,200,000                                    
Cash received related to exercise of options         $ 2,400,000 $ 3,600,000 $ 2,700,000